Biocon signs licensing and supply pact with Biomm S.A for Semaglutide commercialisation in Brazil
Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.